CK
Chitra Khetrapal
About Chitra Khetrapal
Chitra Khetrapal has 23 years in corporate governance. Holds Director role. Currently with 2 companies, including Ess Kay Estate Developers Private Limited and Biomax Health Care (India) Private Limited. Formerly with 2 companies, such as Novelty Ventures Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Biomax Health Care (India) Private Limited
U93000DL1997PTC088290
|
Director | 12 Feb 2003 | 1997 | Active |
|
Enchanted Properties Private Limited
U70100DL2015PTC286487
|
Director | 19 Dec 2022 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Novelty Ventures Private Limited
U82990HR2011PTC084827
|
Director | 17 Aug 2011 | 2011 | Active |
|
Ess Kay Estate Developers Private Limited
U70101HR2011PTC044302
|
Director | 14 Nov 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chitra Khetrapal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chitra Khetrapal
Chitra Khetrapal has 23 years in corporate governance. Holds Director role. Currently with 2 companies, including Ess Kay Estate Developers Private Limited and Biomax Health Care (India) Private Limited. Formerly with 2 companies, such as Novelty Ventures Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Chitra Khetrapal is associated with 2 companies as Director.
Chitra Khetrapal has expertise in General Business, Healthcare.
Chitra Khetrapal has 23 years in corporate governance.